LABAQUA SA

Their core work

Labaqua is a private environmental and water analysis laboratory based in Alicante, Spain, with specialized expertise in the detection and monitoring of waterborne pathogens — particularly Legionella and E. coli in industrial and environmental water systems. They have moved beyond routine laboratory testing into applied R&D: as coordinator of CYTO-WATER, they led development of a portable image cytometry instrument designed for rapid, on-site pathogen identification. Their more recent involvement in PathoCERT extends this expertise into the emergency response domain, where they contribute field knowledge to systems designed to detect and manage large-scale drinking water contamination events. In practice, they sit at the intersection of accredited water testing, rapid diagnostic technology, and public health preparedness — a combination that is rare among private companies.

What they specialise in

How they've shifted over time

In their first H2020 project (2015–2018), Labaqua focused squarely on technology development: building and validating a portable detection instrument for two high-risk waterborne pathogens. That work was lab-driven and product-oriented. By 2020–2024, the focus had shifted from the instrument to the system: PathoCERT's keywords — modelling, fault diagnosis, systems engineering, first responders, public health — describe an operational, multi-actor emergency framework, not a single device. The trajectory is clear: from building a better test to answering the question of what happens when the test finds something serious.

Labaqua appears to be expanding from water testing services into broader public health security roles, particularly around large-scale contamination events — making them an increasingly relevant partner for water utilities, civil protection agencies, and security-focused consortia.

How they like to work

Labaqua has taken on both a leadership role (coordinating CYTO-WATER with a full consortium) and a supporting expert role (third party in PathoCERT), suggesting they can adapt their position depending on where their value is greatest. Despite only two projects, they have worked with 30 distinct partners — a figure driven by participation in large, multi-partner consortia rather than repeated bilateral ties. This points to an organization comfortable operating within complex international networks rather than one that relies on long-standing relationships with familiar partners.

Labaqua has connected with 30 unique partners across 13 countries from just two projects, a network scale that reflects involvement in large-consortium H2020 actions. Their reach is pan-European, with no evidence of a tight regional cluster.

What sets them apart

Labaqua is a rare case in EU research: a private, non-SME water analysis company that has both led a funded project and contributed operational expertise to a security-focused emergency response consortium — roles more commonly held by universities or research institutes. Their credibility comes from being an accredited testing laboratory with real field operations, not a purely academic partner, which means they can translate research outputs into commercially deployable services. For consortia building water safety or public health projects, Labaqua offers something universities cannot: direct access to operational water testing workflows and existing relationships with water utilities and public health authorities.

Highlights from their portfolio

• CYTO-WATER
  Labaqua served as coordinator — unusual for a private testing company — leading a multi-partner consortium to develop a portable image cytometer for rapid Legionella and E. coli detection, the project that defines their R&D identity.
• PathoCERT
  Their involvement in this large security-pillar project on pathogen contamination emergency response signals a deliberate move into the public health security space, extending beyond lab services into first-responder and crisis management systems.